1-5 of 5
Christine Schmitz, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Combination of High Total Metabolic Tumor Volume and Poor ECOG Performance Status Defines Ultra-High Risk Diffuse Large B-Cell Lymphoma. Validation across Multiple Cohorts of Large Clinical Trials and in Real World

Catherine Thieblemont, MD PhD, Loïc Chartier, Ulrich Dührsen, Prof, MD PhD, Umberto Vitolo, MD, Sally F Barrington, Prof, MD PhD, Laetitia Vercellino, Jan Zaucha, MDPhD, Inês Patrocinio Carvalho, Gomes da Silva Maria, MD PhD, Pierre Decazes, Pierre-Julien Viailly, Herve Tilly, MD PhD, Alina Berriolo-Riedinger, Rene-Olivier Casasnovas, MD, Andreas Hüttmann, MD, Hajira Ilyas, George Mikhaeel, Prof, MD PhD, Joel Dunn, Anne Ségolène Cottereau, MD, Christine Schmitz, MD, Joseph N. Paulson, Tina G Nielsen, Michel Meignan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-136544
Published: 2020
Journal Articles

Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial

Julia Richter, PhD, Andreas Hüttmann, MD, Jan Rekowski, MSc, Christine Schmitz, MD, Selina Gärtner, MS, BS, Claudia Ose, MSc, Andreas Rosenwald, Martin-Leo Hansmann, Sylvia Hartmann, MD, Peter Moeller, MD, Hans-Heinrich Wacker, MD, Alfred Feller, Christoph Thorns, MD, Stefan P. Müller, MD, Ulrich Duehrsen, MD, Wolfram Klapper, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4188.
https://doi.org/10.1182/blood-2018-99-112815
Published: 2018
Journal Articles

Interim PET-Based Outcome Prediction in Diffuse Large B-Cell Lymphoma Patients Participating in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) Trial: Comparison of the Delta SUV Max Method and the Deauville 5-Point Scale

Jan Rekowski, MSc, Andreas Hüttmann, MD, Christine Schmitz, MD, Stefan P. Müller, MD, Karl-Heinz Jöckel, PhD, Ulrich Duehrsen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1696.
https://doi.org/10.1182/blood-2018-99-118317
Published: 2018
Journal Articles

Circulating Tumor DNA Is a Reliable Measure of Tumor Burden at Diagnosis of Diffuse Large B Cell Lymphoma: An International Reproducibility Study

David M. Kurtz, MD, Michael Jin, Joanne Soo, BS, Florian Scherer, MD, Alexander Craig, MPhil, Jacob J Chabon, Joseph G Schroers-Martin, MD, Chih Long Liu, PhD, Henning Stehr, PhD, Christine Schmitz, MD, Ulrich Duehrsen, MD, Andreas Hüttmann, MD, Anne Ségolène Cottereau, Michel Meignan, Olivier Casasnovas, MD, Jason R. Westin, MD, Gianluca Gaidano, MD PhD, Davide Rossi, MD PhD, Mark Roschewski, MD, Wyndham H. Wilson, MD PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 310.
https://doi.org/10.1182/blood.V130.Suppl_1.310.310
Published: 2017
Journal Articles

AÂ New Dynamic PET-Based Scoring System Improves Outcome Prediction in Patients with Diffuse Large B-Cell Lymphoma

Christine Schmitz, MD, Andreas Hüttmann, MD, Stefan P. Müller, MD, Marcus Brinkmann, Dipl.-Biol., Ulrich Duehrsen, MD, Jan Rekowski, Dipl.-Stat
Journal: Blood
Blood (2017) 130 (Supplement 1): 2832.
https://doi.org/10.1182/blood.V130.Suppl_1.2832.2832
Published: 2017